Melissa Cummings is the Chief Operating Officer at Progyny, playing a critical role in scaling Progyny’s operations and building on capabilities and advancing the differentiated service and support Progyny offers today. Known as a dynamic change leader with a deep customer and provider focus, Melissa brings a broad skill set spanning P&L leadership, corporate strategy, product development, sales, technology, and operations. Her ability to lead with both vision and execution has consistently delivered measurable results and improved outcomes for organizations, clients, and the communities they serve.
Prior to joining Progyny, Melissa served as EVP and Chief Customer Officer at Blue Cross and Blue Shield of RI (BCBSRI) where she led record growth, retention and brand recognition for this $2 billion plan across both commercial and government segments. Melissa led the evolution of the firm’s retail strategy, along with a number of market-leading customer service capabilities – including the first of its kind navigation and advocacy solution – and directed sales, product, marketing, operations and enterprise strategic planning. Melissa has also held senior leadership positions at Aetna (now CVS Health) and CIGNA in business operations, product development and management, underwriting and sales.
Melissa holds a B.A. from the College of the Holy Cross and an M.B.A. in Health Care Management from the University of Connecticut. She is deeply involved with the American Heart Association, serving as Past Board Chair for the Southern New England Board of Directors, and a former Go Red chairperson. She currently serves on the Board for RI PBS/NPR and chairs the organization’s Development Committee.
What is Melissa B. Cummings' net worth?
The estimated net worth of Melissa B. Cummings is at least $1.90 million as of May 19th, 2026. Cummings owns 73,371 shares of Progyny stock worth more than $1,899,649 as of June 4th. This net worth estimate does not reflect any other assets that Cummings may own. Learn More about Melissa B. Cummings' net worth.
How do I contact Melissa B. Cummings?
Has Melissa B. Cummings been buying or selling shares of Progyny?
Over the course of the past ninety days, Melissa B. Cummings has sold $239,450.00 in Progyny stock. Most recently, Melissa B. Cummings sold 9,578 shares of the business's stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $25.00, for a transaction totalling $239,450.00. Following the completion of the sale, the chief operating officer now directly owns 73,371 shares of the company's stock, valued at $1,834,275. Learn More on Melissa B. Cummings' trading history.
Who are Progyny's active insiders?
Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Geoffrey Clapp (Insider), Melissa Cummings (COO), Kevin Gordon (Director), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (Executive Chairman), Cheryl Scott (Director), Michael Sturmer (President), and Allison Swartz (General Counsel). Learn More on Progyny's active insiders.
Are insiders buying or selling shares of Progyny?
In the last twelve months, Progyny insiders bought shares 1 times. They purchased a total of 79,500 shares worth more than $1,931,055.00. In the last twelve months, insiders at the sold shares 17 times. They sold a total of 72,672 shares worth more than $1,760,223.48. The most recent insider tranaction occured on June, 2nd when CFO Mark S Livingston sold 279 shares worth more than $7,309.80. Insiders at Progyny own 9.9% of the company.
Learn More about insider trades at Progyny. Information on this page was last updated on 6/2/2026.
